ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

NCI Sponsors Session At ASCO On Clinical Grant Applications

May 3, 1991

Obituary: Carl Baker, Former NCI Director

March 13, 2009